Fortrea Holdings Inc (FTRE) is expected to report $-0.54 for 1Q.
Fox Corp - Class A (FOX,FOXA) is expected to report $0.92 for 3Q.
Harvard Bioscience Inc (HBIO) is expected to report $-0.10 for 1Q.
Hycroft Mining Holding Corp (HYMC) is expected to report for 1Q.
Imunon Inc (IMNN) is expected to report $-0.38 for 1Q.
K92 Mining is expected to report for 1Q.
Lightbridge Corp (LTBR) is expected to report for 1Q.
Lincoln Educational Services Corp (LINC) is expected to report $-0.02 for 1Q.
LiveOne Inc (LVO) is expected to report $-0.04 for 4Q.
Lyell Immunopharma Inc (LYEL) is expected to report $-0.20 for 1Q.
Macerich Co (MAC) is expected to report $-0.09 for 1Q.
Mineralys Therapeutics Inc (MLYS) is expected to report $-1.07 for 1Q.
NRG Energy Inc (NRG) is expected to report $1.64 for 1Q.
Petrotal Corp (TAL.T) is expected to report for 1Q.
RadNet Inc (RDNT) is expected to report $-0.13 for 1Q.
Ramaco Resources Inc (METC) is expected to report $-0.15 for 1Q.
Redwire Corp (RDW) is expected to report $-0.29 for 1Q.
Sally Beauty Holdings Inc (SBH) is expected to report $0.39 for 2Q.
SelectQuote Inc (SLQT) is expected to report for 3Q.
Sonida Senior Living Corp (SNDA) is expected to report $-0.95 for 1Q.
Southwest Gas Holdings Inc (SWX) is expected to report $1.46 for 1Q.
Stoke Therapeutics Inc (STOK) is expected to report $0.46 for 1Q.
Superior Industries International Inc (SUP) is expected to report $-0.08 for 1Q.
Surgery Partners Inc (SGRY) is expected to report $-0.03 for 1Q.
Tango Therapeutics Inc (TNGX) is expected to report $-0.33 for 1Q.
US Energy Corp (USEG) is expected to report $-0.03 for 1Q.
United Parks & Resorts Inc (PRKS) is expected to report $-0.23 for 1Q.
UroGen Pharma Ltd (URGN) is expected to report $-0.72 for 1Q.
Powered by Kantar Media and Dow Jones.
ANALYST RATINGS ACTIONS
Apellis Pharmaceuticals Cut to Neutral From Buy by B of A Securities
Apellis Pharmaceuticals Cut to Outperform From Strong Buy by Raymond James
CVRx Cut to Underweight From Neutral by JP Morgan
Expedia Group Cut to Underweight From Neutral by Piper Sandler
GeneDx Holdings Raised to Buy From Hold by Jefferies
Holley Cut to Hold From Buy by Benchmark
International Paper Cut to Underweight From Equal-Weight by Wells Fargo
Iovance Biotherapeutics Cut to Market Perform From Market Outperform by JMP Securities
Murphy USA Cut to Market Perform From Outperform by Raymond James
National Vision Raised to Buy From Neutral by Citigroup
Ouster Raised to Buy From Hold by WestPark Capital
Packaging Corp of America Cut to Equal-Weight From Overweight by Wells Fargo
Palmer Square Capital BDC Cut to Perform From Outperform by Oppenheimer
PTC Therapeutics Raised to Buy From Neutral by B of A Securities
Stagwell Cut to Hold From Buy by Benchmark
Vor Biopharma Cut to Market Perform From Market Outperform by JMP Securities
Vor Biopharma Cut to Neutral From Buy by HC Wainwright & Co.
Wolfspeed Cut to Sell From Neutral by Citigroup
Wolfspeed Cut to Underweight From Neutral by JP Morgan
This article is a text version of a Wall Street Journal newsletter published earlier today.
(END) Dow Jones Newswires
05-12-25 0616ET


















